• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AMETEK Announces Appointment of Karleen Oberton to Board of Directors

    2/11/21 8:00:00 AM ET
    $AME
    $HOLX
    Industrial Machinery/Components
    Industrials
    Medical Electronics
    Health Care
    Get the next $AME alert in real time by email

    BERWYN, Pa., Feb. 11, 2021 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has appointed Karleen Oberton as a new director of the Company. Ms. Oberton serves as Chief Financial Officer of Hologic, Inc. (NASDAQ: HOLX), an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment systems.

    "We are pleased to welcome Karleen to AMETEK as a member of our Board of Directors," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Karleen is a skilled business executive with more than 30 years of experience in public accounting, biotechnology and medical device manufacturing. Her strong financial acumen along with her proven executive leadership managing global organizations nicely complements our existing Board skill set."

    Joining Hologic as Vice President and Corporate Controller in 2006, Ms. Oberton has since held roles of increasing responsibility within the company's finance function. In 2014, she was named Corporate Vice President and Chief Accounting Officer and in 2018 was elected Chief Financial Officer. Prior to joining Hologic, Ms. Oberton served as Senior Corporate Controller for ImmunoGen, a biotechnology company developing targeted anticancer therapeutics. Earlier in her career, Ms. Oberton held leadership positions at Ernst & Young and Arthur Andersen.

    Ms. Oberton holds a bachelor's degree in Business Administration from Merrimack College and was an active Certified Public Accountant for more than 18 years.

    Corporate Profile
    AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices with 2020 sales of more than $4.5 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500.

    Contact:
    AMETEK, Inc.
    Kevin Coleman
    Vice President, Investor Relations
    1100 Cassatt Road
    Berwyn, Pennsylvania 19312
    [email protected]
    Phone: 610.889.5247

    SOURCE AMETEK, Inc.

    Related Links

    www.ametek.com

    Get the next $AME alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AME
    $HOLX

    CompanyDatePrice TargetRatingAnalyst
    AMETEK Inc.
    $AME
    9/10/2025$200.00Equal Weight
    Barclays
    AMETEK Inc.
    $AME
    9/2/2025$180.00Sell → Hold
    TD Cowen
    Hologic Inc.
    $HOLX
    8/18/2025$80.00Hold → Buy
    Argus
    Hologic Inc.
    $HOLX
    8/6/2025$87.00Sector Perform → Outperform
    RBC Capital Mkts
    AMETEK Inc.
    $AME
    7/14/2025$192.00Buy → Hold
    Melius
    Hologic Inc.
    $HOLX
    7/9/2025$80.00Neutral → Buy
    Citigroup
    Hologic Inc.
    $HOLX
    5/27/2025Hold
    Needham
    AMETEK Inc.
    $AME
    4/14/2025$170.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $AME
    $HOLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 29, 2024 - FDA Roundup: October 29, 2024

    For Immediate Release: October 29, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA responded to objections on the agency’s final rule that removed the authorized food contact uses of most phthalates because industry abandoned these uses. The FDA evaluated the objections and concluded that they did not provide a basis for mod

    10/29/24 3:30:19 PM ET
    $HOLX
    Medical Electronics
    Health Care

    February 2, 2024 - FDA Roundup: February 2, 2024

    For Immediate Release: February 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a safety communication to warn consumers, health care providers, and health care facilities not to use certain Cardinal Health Monoject luer-lock and enteral syringes. Dimensional changes made to the syringes, when used with syringe pump

    2/2/24 3:58:21 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $AME
    $HOLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Barclays initiated coverage on Ametek with a new price target

    Barclays initiated coverage of Ametek with a rating of Equal Weight and set a new price target of $200.00

    9/10/25 3:58:10 PM ET
    $AME
    Industrial Machinery/Components
    Industrials

    Ametek upgraded by TD Cowen with a new price target

    TD Cowen upgraded Ametek from Sell to Hold and set a new price target of $180.00

    9/2/25 8:19:51 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    Hologic upgraded by Argus with a new price target

    Argus upgraded Hologic from Hold to Buy and set a new price target of $80.00

    8/18/25 9:05:38 AM ET
    $HOLX
    Medical Electronics
    Health Care

    $AME
    $HOLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, President and CEO Macmillan Stephen P sold $9,266,118 worth of shares (138,358 units at $66.97) and exercised 138,358 shares at a strike of $39.96 (SEC Form 4)

    4 - HOLOGIC INC (0000859737) (Issuer)

    9/23/25 4:10:08 PM ET
    $HOLX
    Medical Electronics
    Health Care

    PRES. - ELECTRONIC INSTRUMENTS Hardin John Wesley sold $1,479,232 worth of shares (7,867 units at $188.03), acquired 80 units of Common Stock/ Serp and acquired 2 units of 401k Plan, decreasing direct ownership by 68% to 23,084 units (SEC Form 4)

    4 - AMETEK INC/ (0001037868) (Issuer)

    9/12/25 4:03:36 PM ET
    $AME
    Industrial Machinery/Components
    Industrials

    CHIEF EXECUTIVE OFFICER Zapico David A acquired 210 units of Common Stock/ Serp and returned $6,725,152 worth of Common Stock/ Serp to the company (35,973 units at $186.95), decreasing direct ownership by 60% to 23,982 units (SEC Form 4)

    4 - AMETEK INC/ (0001037868) (Issuer)

    8/26/25 4:11:43 PM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HOLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

    Hologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2025 on Monday, November 3, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 800-330-6710 (in the United States and Canada) or +1 312-471-1353 (for international callers) and referencing access code 5756948. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. Hologic will provide a live and webcast replay of the call on the Company's website at investors.hologic.

    10/2/25 4:04:00 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

    New Panther Fusion Gastrointestinal Bacterial and Expanded Bacterial Assays deliver tailored, actionable diagnostic results to support fast and informed patient care Hologic, Inc. (NASDAQ:HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fusion® Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The company also announced that the assays obtained CE marking in the European Union in accordance with In Vitro Diagnostic Regulation (IVDR). These highly sensitive molecular tests are designed to rapidly detect the most common bacterial pathogens responsible for infectious gastroenteritis. This press release features

    10/2/25 8:05:00 AM ET
    $HOLX
    Medical Electronics
    Health Care

    New Survey Results Underscore the Need to #BustTheMyth About Mammograms

    Poll of over 1,100 women shows that misconceptions around breast cancer remain a major barrier to potentially lifesaving screenings Global women's health leader Hologic, Inc. (NASDAQ:HOLX) will mark the start of Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 19th year. The company will also continue its comprehensive #BustTheMyth patient education campaign following new survey data that shows nearly half of women who are recommended a mammogram either skip or delay the exam. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250930999859/en/Bust the Myth "For 40 years, Hologic has been dedicated to develo

    9/30/25 8:15:00 AM ET
    $HOLX
    Medical Electronics
    Health Care

    $AME
    $HOLX
    SEC Filings

    View All

    SEC Form 144 filed by Hologic Inc.

    144 - HOLOGIC INC (0000859737) (Subject)

    9/22/25 4:25:42 PM ET
    $HOLX
    Medical Electronics
    Health Care

    Hologic Inc. filed SEC Form 8-K: Leadership Update

    8-K - HOLOGIC INC (0000859737) (Filer)

    9/19/25 4:05:37 PM ET
    $HOLX
    Medical Electronics
    Health Care

    SEC Form S-8 POS filed by AMETEK Inc.

    S-8 POS - AMETEK INC/ (0001037868) (Filer)

    7/31/25 3:01:11 PM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HOLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Madaus Martin D bought $300,760 worth of shares (5,445 units at $55.24) (SEC Form 4)

    4 - HOLOGIC INC (0000859737) (Issuer)

    5/9/25 4:39:33 PM ET
    $HOLX
    Medical Electronics
    Health Care

    $AME
    $HOLX
    Leadership Updates

    Live Leadership Updates

    View All

    AMETEK to Acquire FARO Technologies

    BERWYN, Pa., and LAKE MARY, Fla., May 6, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) and FARO Technologies, Inc. (NASDAQ:FARO) today announced that they have entered into a definitive agreement under which AMETEK will acquire all outstanding shares of FARO Technologies common stock for $44 per share in cash, which represents an approximate 40% premium to FARO's closing price on May 5, 2025. The transaction values FARO at an enterprise value of approximately $920 million. The boards of directors of both companies have unanimously approved the transaction. Founded in 1981 and headquartered in Lake Mary, Florida, FARO Technologies is a leading provider of 3D measurement and imaging solutions,

    5/6/25 7:30:00 AM ET
    $AME
    $FARO
    Industrial Machinery/Components
    Industrials

    AMETEK Appoints Jennifer G. Hellberg Vice President, Human Resources

    BERWYN, Pa., March 3, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of Jennifer G. Hellberg as Vice President, Human Resources. Ms. Hellberg most recently served as Divisional Vice President and Business Unit Manager for the Zygo and Navitar businesses within AMETEK's Ultra Precision Technologies Division. "I am pleased to announce Jennifer's promotion to Vice President, Human Resources," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Jennifer has demonstrated outstanding leadership and strategic vision during her time at AMETEK. I am confident she will continue to enhance our global human resources organization and support AMETEK's l

    3/3/25 8:00:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    AMETEK Appoints William P. Callahan Vice President and General Manager, Aerospace & Defense Division

    BERWYN, Pa., Feb. 7, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced the appointment of William P. Callahan as Vice President and General Manager, Aerospace & Defense Division.   "I am delighted to welcome Bill to AMETEK and pleased he will be taking on this important leadership role with the company," commented David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Bill's extensive P&L management experience, strong operational expertise, and proven leadership skills make him ideally suited for this role." Mr. Callahan brings a strong track record of experience and success, having most recently served as Group General Manager at Amphenol Corporation. Prior to that, Mr.

    2/7/25 8:00:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HOLX
    Financials

    Live finance-specific insights

    View All

    Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

    Hologic, Inc. (NASDAQ:HOLX) announced today that the Company plans to release its financial results for the fourth quarter of fiscal 2025 on Monday, November 3, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 800-330-6710 (in the United States and Canada) or +1 312-471-1353 (for international callers) and referencing access code 5756948. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins. Hologic will provide a live and webcast replay of the call on the Company's website at investors.hologic.

    10/2/25 4:04:00 PM ET
    $HOLX
    Medical Electronics
    Health Care

    AMETEK Declares Quarterly Dividend

    BERWYN, Pa., Aug. 8, 2025 /PRNewswire/ -- The Board of Directors of AMETEK, Inc. (NYSE:AME) declared a regular quarterly dividend of $0.31 per share for the third quarter ending September 30, 2025. This third quarter dividend is payable September 30, 2025 to shareholders of record as of September 15, 2025. Corporate Profile AMETEK (NYSE:AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annual sales of approximately $7.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, Technology Innovation, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focu

    8/8/25 8:00:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    AMETEK Announces Record Second Quarter Results and Raises Full Year Guidance

    BERWYN, Pa., July 31, 2025 /PRNewswire/ -- AMETEK, Inc. (NYSE:AME) today announced its financial results for the second quarter ended June 30, 2025. AMETEK's second quarter 2025 sales were a record $1.78 billion, a 2.5% increase over the second quarter of 2024. Operating income increased 3% to $461.6 million and operating margins were up 20 basis points to 26.0% versus the prior year.   On a GAAP basis, second quarter earnings per diluted share were $1.55. Adjusted earnings in the quarter were $1.78 per diluted share, up 7% from the second quarter of 2024. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.23 per diluted share. A reconciliatio

    7/31/25 6:55:00 AM ET
    $AME
    Industrial Machinery/Components
    Industrials

    $AME
    $HOLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hologic Inc.

    SC 13G/A - HOLOGIC INC (0000859737) (Subject)

    11/14/24 1:28:29 PM ET
    $HOLX
    Medical Electronics
    Health Care

    SEC Form SC 13G filed by Hologic Inc.

    SC 13G - HOLOGIC INC (0000859737) (Subject)

    2/14/24 10:04:34 AM ET
    $HOLX
    Medical Electronics
    Health Care

    SEC Form SC 13G/A filed by AMETEK Inc. (Amendment)

    SC 13G/A - AMETEK INC/ (0001037868) (Subject)

    2/13/24 4:58:53 PM ET
    $AME
    Industrial Machinery/Components
    Industrials